Acne Vulgaris (Cutibacterium acnes)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Acne vulgaris is a common skin condition that mainly affects the hair follicles and sebaceous glands of the face, chest, and back. It occurs when these follicles become clogged with oil and dead skin cells, leading to the formation of pimples, blackheads, and whiteheads. The condition often appears during adolescence but can persist into adulthood. It involves inflammation caused by the bacteria Cutibacterium acnes, which normally lives on the skin but can trigger irritation when trapped in clogged pores. Acne can affect a person's appearance and may cause scarring or emotional distress. The skin system is primarily involved, and the main health impact is on the skin's appearance and texture.
Clinical Definition
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous units characterized by the formation of comedones, papules, pustules, nodules, and possible scarring. The core pathology involves hyperkeratinization of the follicular epithelium, increased sebum production by sebaceous glands, colonization by Cutibacterium acnes, and subsequent inflammation. The condition is most common in adolescents due to hormonal changes that increase sebum secretion. The presence of C. acnes promotes inflammation by activating the innate immune response, leading to the characteristic lesions. Clinically, acne can range from mild comedonal acne to severe nodulocystic forms with risk of permanent scarring. It is a significant dermatologic condition due to its high prevalence and potential psychosocial impact.
Inciting Event
Onset of pubertal hormonal changes increases androgen levels and sebum production.
Initial follicular hyperkeratinization leads to comedone formation.
Cutibacterium acnes, a normal skin resident, contributes to inflammation in susceptible follicles; acne is not a contagious infection.
Latency Period
There is no single fixed latency period between hormonal changes and clinical acne.
Lesion duration varies: superficial lesions often resolve within weeks, while deep nodules may persist for months.
Diagnostic Delay
Mild cases may be mistaken for simple folliculitis or dermatitis.
Patients may delay seeking care due to embarrassment or normalization of acne.
Misattribution to poor hygiene or diet can delay appropriate treatment.
Clinical Presentation
Signs & Symptoms
Multiple comedones, papules, pustules, nodules, and cysts localized to sebaceous gland-rich areas.
Tenderness and erythema over inflamed lesions are common.
Oily skin due to increased sebum production often precedes lesion development.
Patients may report itching or burning sensations in affected areas.
Psychosocial distress including anxiety and depression can occur due to visible skin lesions.
History of Present Illness
Gradual onset of comedones followed by inflammatory papules and pustules on face, chest, and back.
Lesions often wax and wane with periods of exacerbation and improvement.
Patients report tenderness or pain with nodulocystic lesions.
Possible scarring or post-inflammatory hyperpigmentation in chronic cases.
Past Medical History
History of hormonal disorders such as polycystic ovary syndrome may worsen acne.
Previous use of topical or systemic corticosteroids can exacerbate acneiform eruptions.
Prior episodes of acne or other skin conditions may influence severity.
Family History
Positive family history of acne vulgaris increases risk and severity.
Inherited susceptibility contributes to acne; family history is more clinically useful than attributing an individual case to a specific gene.
Family members may have histories of severe nodulocystic acne or scarring.
Physical Exam Findings
Presence of comedones including open (blackheads) and closed (whiteheads) primarily on the face, chest, and back.
Inflammatory papules and pustules are common and indicate active follicular inflammation.
Nodules and cysts may be present in severe cases, often painful and deep-seated.
Scarring such as icepick, boxcar, or hypertrophic scars may be visible in chronic or severe acne.
Post-inflammatory hyperpigmentation is frequently observed in darker skin types following lesion resolution.
Diagnostic Workup
Diagnostic Criteria
Diagnosis is clinical, based on comedones and inflammatory lesions in typical sebaceous areas. Culture of C. acnes does not establish acne. Abrupt ulcerative acne with fever or joint pain warrants urgent assessment, including for acne fulminans.
Pathophysiology
Key Mechanisms
Increased sebum production driven by androgen stimulation leads to follicular occlusion.
Follicular hyperkeratinization causes obstruction of the pilosebaceous unit.
Cutibacterium acnes contributes to immune signaling in susceptible follicles; its presence alone does not explain acne or its severity.
Release of proinflammatory cytokines and neutrophil recruitment results in papules, pustules, and nodules.
Formation of comedones (open and closed) is the hallmark lesion due to follicular plugging.
| Involvement | Details |
|---|---|
| Organs | Skin is the organ affected by acne vulgaris, manifesting with comedones, papules, pustules, and nodules |
Endocrine glands influence acne severity through androgen production affecting sebaceous glands | |
| Tissues | Pilosebaceous unit is the primary site of acne pathology involving hair follicle and sebaceous gland |
Epidermis undergoes hyperkeratinization contributing to follicular plugging | |
Dermis contains inflammatory infiltrates in inflamed acne lesions | |
| Cells | Keratinocytes contribute to follicular hyperkeratinization leading to comedone formation |
Sebocytes in sebaceous glands produce excess sebum that promotes acne development | |
Neutrophils infiltrate inflamed lesions causing pustule formation and tissue damage | |
T helper cells mediate inflammatory responses in acne lesions | |
| Chemical Mediators | Interleukin-1 (IL-1) promotes follicular hyperkeratinization and inflammation |
Tumor necrosis factor-alpha (TNF-α) drives local inflammation in acne lesions | |
Lipases produced by Cutibacterium acnes hydrolyze sebum triglycerides into irritating free fatty acids | |
Androgens stimulate sebaceous gland activity and sebum production |
Treatments
Pharmacological Treatments
Topical retinoids
- Mechanism:
Normalize follicular epithelial desquamation and reduce microcomedone formation
- Side effects:
Skin irritation
Photosensitivity
Dryness
- Clinical role:
First-line
Topical benzoyl peroxide
- Mechanism:
Exerts bactericidal activity against Cutibacterium acnes and reduces inflammation
- Side effects:
Skin irritation
Dryness
Bleaching of fabrics
- Clinical role:
First-line
Topical antibiotics (e.g., clindamycin, erythromycin)
- Mechanism:
Inhibit bacterial protein synthesis to reduce Cutibacterium acnes colonization
- Side effects:
Skin irritation
Antibiotic resistance
- Clinical role:
Use for inflammatory acne with benzoyl peroxide to reduce resistance; avoid antibiotic monotherapy.
Oral antibiotics (e.g., doxycycline, minocycline)
- Mechanism:
Reduce Cutibacterium acnes and exert anti-inflammatory effects
- Side effects:
Gastrointestinal upset
Photosensitivity
Tooth discoloration in children
- Clinical role:
For moderate-to-severe inflammatory acne, use a limited course with benzoyl peroxide and appropriate non-antibiotic topical therapy; avoid concurrent topical antibiotics.
Oral isotretinoin
- Mechanism:
Decreases sebaceous gland size and sebum production, normalizes keratinization, and reduces Cutibacterium acnes
- Side effects:
Teratogenicity
Dry skin and mucous membranes
Elevated liver enzymes
Hyperlipidemia
- Clinical role:
A supervised course for severe or treatment-resistant acne. Assess mood, monitor lipids and liver tests, and follow applicable pregnancy testing and prevention requirements.
Topical azelaic acid
- Mechanism:
Antimicrobial and comedolytic effects with anti-inflammatory properties
- Side effects:
Skin irritation
Hypopigmentation has been reported in isolated cases
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Regular gentle cleansing to reduce excess sebum and debris without over-drying the skin
Avoidance of comedogenic cosmetics and skin products
Use of non-oily, non-comedogenic moisturizers and sunscreens
Light-based procedures may be considered selectively, but current evidence does not support a broad routine recommendation for acne.
Extraction of comedones by trained professionals in select cases
Prevention
Pharmacological Prevention
Maintenance is optional. For frequent relapse, consider adapalene with benzoyl peroxide; non-antibiotic topical monotherapy may be used when that combination is unsuitable.
Topical benzoyl peroxide reduces Cutibacterium acnes colonization and inflammation.
Oral antibiotics treat active inflammatory acne for a limited course; they are not routine prophylaxis or maintenance.
Hormonal therapies such as combined oral contraceptives reduce androgen-driven sebum production in females.
Isotretinoin is a supervised treatment course, not routine prophylaxis; acne can relapse after treatment.
Non-pharmacological Prevention
Gentle skin cleansing twice daily with non-comedogenic products reduces follicular occlusion.
Avoidance of oily or comedogenic cosmetics and skin products prevents exacerbation.
Minimizing mechanical irritation or picking of lesions reduces risk of scarring and infection.
A balanced diet is appropriate; evidence is insufficient to prescribe a specific restrictive diet as routine acne treatment or prevention.
Stress can aggravate acne. Support wellbeing and treatment adherence; stress management is not established as a reliable standalone preventive treatment.
Outcome & Complications
Complications
Permanent scarring including atrophic and hypertrophic scars is a major complication.
Post-inflammatory hyperpigmentation can cause prolonged cosmetic concerns.
Secondary bacterial infection may occur with excoriated or manipulated lesions.
Psychological morbidity such as low self-esteem and social withdrawal is significant.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Acne Vulgaris (Cutibacterium acnes) versus Rosacea
Acne Vulgaris (Cutibacterium acnes) | Rosacea |
|---|---|
Commonly begins in adolescence or young adulthood | Usually begins in adulthood, often after age 30, although other ages are possible |
Predominantly affects face with comedones, papules, and pustules | Central facial erythema with telangiectasias, absence of comedones |
Colonization by Cutibacterium acnes contributes to inflammation | Multifactorial inflammation with possible microbiome and Demodex associations; bacterial absence does not distinguish rosacea |
Treatment depends on severity; antibiotics, when needed, are combined with appropriate non-antibiotic topical therapy | Improves with topical metronidazole or ivermectin |
Acne Vulgaris (Cutibacterium acnes) versus Folliculitis
Acne Vulgaris (Cutibacterium acnes) | Folliculitis |
|---|---|
Involves overgrowth of Cutibacterium acnes | May involve staphylococci, Pseudomonas or Malassezia; noninfectious causes also occur |
Comedones, papules, and pustules with deeper follicular involvement | Often uniform follicular papules or pustules without comedones; some forms involve deeper follicles |
Chronic or recurrent course with waxing and waning severity | Course depends on cause and may be acute, persistent or recurrent, requiring specific treatment |
Acne Vulgaris (Cutibacterium acnes) versus Seborrheic Dermatitis
Acne Vulgaris (Cutibacterium acnes) | Seborrheic Dermatitis |
|---|---|
Inflammatory papules and pustules with comedones | Erythematous plaques with greasy yellow scales |
Primarily affects face, chest, and back with follicular involvement | Affects scalp, eyebrows, nasolabial folds, and chest |
Involves Cutibacterium acnes bacterial proliferation | Associated with Malassezia yeast overgrowth |
Acne Vulgaris (Cutibacterium acnes) versus Perioral Dermatitis
Acne Vulgaris (Cutibacterium acnes) | Perioral Dermatitis |
|---|---|
Lesions involve face including forehead, cheeks, and chin | Papulopustular eruption around mouth sparing vermilion border |
Corticosteroids can aggravate acne or cause acneiform eruptions; facial topical steroids also cause acne mimics | Often linked to topical corticosteroid use |
Presence of comedones along with inflammatory lesions | Small papules and pustules without comedones |
Acne Vulgaris (Cutibacterium acnes) versus Miliaria (Heat Rash)
Acne Vulgaris (Cutibacterium acnes) | Miliaria (Heat Rash) |
|---|---|
Comedones, papules, and pustules from follicular inflammation | Small, clear vesicles or papules due to sweat duct obstruction |
Chronic or recurrent; trapped heat, sweat, friction and occlusion can aggravate acne | Usually improves with cooling and reduction of sweating or occlusion |
Typically begins in adolescence or young adulthood | Common in infants and in hot, humid conditions |